Last reviewed · How we verify

Adalimumab North American source

Synermore Biologics Co., Ltd. · Phase 1 active Biologic

At a glance

Generic nameAdalimumab North American source
SponsorSynermore Biologics Co., Ltd.
ModalityBiologic
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results